共 50 条
- [21] INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 418 - 424
- [22] Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 1537 - 1541
- [25] Corneal Neovascularization: An Anti-VEGF Therapy Review [J]. SURVEY OF OPHTHALMOLOGY, 2012, 57 (05) : 415 - 429
- [26] ANTI-VEGF DRUGS AS THE 2009 FIRST-LINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1062 - 1066
- [28] Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy [J]. Eye, 2022, 36 : 1113 - 1114